Home › Nasopharyngeal Carcinoma › Oklahoma › Oklahoma City
Nasopharyngeal Carcinoma clinical trials in Oklahoma City, OK
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
RecruitingPhase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
RecruitingPhase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Nasopharyngeal Carcinoma trials in other cities
- Atlanta, GA6 studies
- Houston, TX3 studies
- Pittsburgh, PA3 studies
- Richmond, VA3 studies
- Cincinnati, OH3 studies
- Los Angeles, CA3 studies
- Charlotte, NC3 studies
- Washington, DC3 studies
- Milwaukee, WI3 studies
- Chicago, IL3 studies
- San Francisco, CA3 studies
Other studies in Oklahoma City
- Non-Small Cell Lung Cancer28 studies
- Ovarian Cancer28 studies
- Endometrial Cancer25 studies
- Colorectal Cancer22 studies
- Prostate Cancer21 studies
- Lung Cancer19 studies
- Breast Cancer17 studies
- Metastatic Cancer16 studies
- Cancer (all types)14 studies
- Acute Myeloid Leukemia14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Bladder Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.